(Q36093993)

12 August 2017

1 reference

title

Endothelial cell dysfunction: can't live with it, how to live without it. (English)

1 reference

12 August 2017

0 references

Michael S Goligorsky

1

1 reference

12 August 2017

publication date

1 May 2005

1 reference

American Journal of Physiology - Renal Physiology

12 August 2017

published in

1 reference

12 August 2017

volume

288

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

F871-80

1 reference

Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Gene transfer of endothelial nitric oxide synthase improves nitric oxide-dependent endothelial function in a hypertensive rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Impaired endothelium-dependent vasodilatation in renal failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

The clinical pharmacology of L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Endothelial dysfunction in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Responses of coronary arteries of cardiac transplant patients to acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

The vascular effects of L-Arginine in humans. The role of endogenous insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

The role of folic acid in the prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Tetrahydrobiopterin improves endothelium-dependent vasodilation in nitroglycerin-tolerant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Cellular and molecular mechanisms of endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Gene therapy for cardiovascular disease: a case for cautious optimism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Paradoxical overexpression and translocation of connexin43 in homocysteine-treated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Interactions among ACE, kinins and NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Treatment of coronary heart disease with folic acid: is there a future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Association of eNOS Glu298Asp polymorphism with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Apoptosis in the vascular wall and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Sepiapterin treatment in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Antioxidants and the bioactivity of endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Endothelial function and nitric oxide: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00333.2004

10.1152/AJPRENAL.00333.2004

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference